Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00558831 · ClinicalTrials.gov registry record · NA

Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris

A NA study of Acne Vulgaris, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT00558831 is a NA study of Acne Vulgaris that has completed, run by Northwestern University. The registered enrollment target is 11 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00558831, a NA study of Acne Vulgaris, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy of a benzoyl peroxide 2.5% cream formulation plus a moisturizing lotion versus benzoyl peroxide 2.5% cream alone for the treatment of acne vulgaris.

Conditions Studied

Interventions

  • DRUG Benzoyl Peroxide
  • DRUG Moisturizing Lotion

Study Locations (1)

Illinois

  • Northwestern University Department of Dermatology - Chicago

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2007-10
Est. Completion 2008-01
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00558831

The ClinicalTrials.gov registry entry for NCT00558831 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (96% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 2 interventions - of which Benzoyl Peroxide is the first listed.

NCT00558831 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00558831 about?

NCT00558831 is a clinical study titled "Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris". The purpose of this study is to compare the efficacy of a benzoyl peroxide 2.5% cream formulation plus a moisturizing lotion versus benzoyl peroxide 2.5% cream alone for the treatment of acne vulgaris.

What is the current status of trial NCT00558831?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2007-10. Estimated completion is 2008-01.

What conditions does trial NCT00558831 study?

This clinical trial studies the following conditions: Acne Vulgaris.

What interventions are being tested in trial NCT00558831?

The interventions under investigation include: Benzoyl Peroxide (DRUG), Moisturizing Lotion (DRUG).

Who is sponsoring clinical trial NCT00558831?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00558831 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne Vulgaris

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.